Covaxin 77.8% Effective Against Covid-19, 65.2% Against Delta Variant: Lancet Study

The efficacy was analysed through evaluation of 130 confirmed cases, with 24 observed in the vaccine group versus 106 in the placebo group.

Source: Top India News- News18.com